CG Oncology, Inc. (CGON)
NASDAQ: CGON · IEX Real-Time Price · USD
35.91
+0.69 (1.94%)
Jul 22, 2024, 10:18 AM EDT - Market open
CG Oncology Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$64.00
Upside
+78.25%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | +81.03% | Jun 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +108.88% | May 28, 2024 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $43 → $50 | Hold → Strong Buy | Upgrades | $43 → $50 | +39.26% | May 14, 2024 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $50 | Hold → Strong Buy | Upgrades | $50 | +39.26% | May 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +108.88% | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +108.88% | May 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $75 | Buy | Reiterates | $75 | +108.88% | May 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $75 | Buy | Reiterates | $75 | +108.88% | May 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +108.88% | Apr 4, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $75 | Buy | Initiates | $75 | +108.88% | Feb 20, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $42 | Hold | Initiates | $42 | +16.98% | Feb 20, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $55 | Buy | Initiates | $55 | +53.18% | Feb 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $75 | Strong Buy | Initiates | $75 | +108.88% | Feb 14, 2024 |